Literature DB >> 23398049

Epiplakin modifies the motility of the HeLa cells and accumulates at the outer surfaces of 3-D cell clusters.

Hiromitsu Shimada1, Akiko Nambu-Niibori, Masayo Wilson-Morifuji, Souhei Mizuguchi, Norie Araki, Hideaki Sumiyoshi, Mitsuru Sato, Yoshihiro Mezaki, Haruki Senoo, Kazushi Ishikawa, Yutaka Hatano, Osamu Okamoto, Sakuhei Fujiwara.   

Abstract

Elimination of epiplakin (EPPK) by gene targeting in mice results in acceleration of keratinocyte migration during wound healing, suggesting that epithelial cellular EPPK may be important for the regulation of cellular motility. To study the function of EPPK, we developed EPPK knock-down (KD) and EPPK-overexpressing HeLa cells and analyzed cellular phenotypes and motility by fluorescence/differential interference contrast time-lapse microscopy and immunolocalization of actin and vimentin. Cellular motility of EPPK-KD cells was significantly elevated, but that of EPPK-overexpressing cells was obviously depressed. Many spike-like projections were observed on EPPK-KD cells, with fewer such structures on overexpressing cells. By contrast, in EPPK-KD cells, expression of E-cadherin was unchanged but vimentin fibers were thinner and sparser than in controls, and they were more concentrated at the peri-nucleus, as observed in migrating keratinocytes at wound edges in EPPK(-/-) mice. In Matrigel 3-D cultures, EPPK co-localized on the outer surface of cell clusters with zonula occludens-1 (ZO-1), a marker of tight junctions. Our results suggest that EPPK is associated with the machinery for cellular motility and contributes to tissue architecture via the rearrangement of intermediate filaments.
© 2013 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398049     DOI: 10.1111/1346-8138.12076

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.

Authors:  Yadi Zhou; Yuan Liu; Shagun Gupta; Mauricio I Paramo; Yuan Hou; Chengsheng Mao; Yuan Luo; Julius Judd; Shayne Wierbowski; Marta Bertolotti; Mriganka Nerkar; Lara Jehi; Nir Drayman; Vlad Nicolaescu; Haley Gula; Savaş Tay; Glenn Randall; Peihui Wang; John T Lis; Cédric Feschotte; Serpil C Erzurum; Feixiong Cheng; Haiyuan Yu
Journal:  Nat Biotechnol       Date:  2022-10-10       Impact factor: 68.164

2.  A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19.

Authors:  Yadi Zhou; Yuan Liu; Shagun Gupta; Mauricio I Paramo; Yuan Hou; Chengsheng Mao; Yuan Luo; Julius Judd; Shayne Wierbowski; Marta Bertolotti; Mriganka Nerkar; Lara Jehi; Nir Drayman; Vlad Nicolaescu; Haley Gula; Savaş Tay; Glenn Randall; John T Lis; Cédric Feschotte; Serpil C Erzurum; Feixiong Cheng; Haiyuan Yu
Journal:  Res Sq       Date:  2022-06-07

3.  The acute transcriptomic and proteomic response of HC-04 hepatoma cells to hepatocyte growth factor and its implications for Plasmodium falciparum sporozoite invasion.

Authors:  Dingyin Tao; Jonas G King; Rebecca E Tweedell; Philipp J Jost; Justin A Boddey; Rhoel R Dinglasan
Journal:  Mol Cell Proteomics       Date:  2014-02-16       Impact factor: 5.911

Review 4.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

5.  Comparative genomics reveals evolutionary loss of epiplakin in cetaceans.

Authors:  Peter Fuchs; Corinne Drexler; Sonia Ratajczyk; Leopold Eckhart
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.